ARHGEF15 Promotes Endothelial Cell Migration Through the Regulation of STAT3 Signaling

Abstract

Objective

Rho guanine nucleotide exchange factor 15 (ARHGEF15) is a member of the RhoGEF family that activates the Rho protein. High ARHGEF15 expression is associated with poor prognosis in patients with pancreatic cancer. Although ARHGEF15 is abundantly expressed in endothelial cells, its detailed functions remain unknown. This study aimed to elucidate the effects of ARHGEF15 on endothelial cells and the underlying molecular mechanisms involved.

Methods

The ARHGEF15 gene was overexpressed or knocked down in human umbilical vein endothelial cells (HUVECs), and the results were validated via qRT-PCR and Western blotting. CCK8 and MTT assays were used to evaluate cell proliferation. Wound healing and transwell assays were used to assess cell migration. The activation of STAT3 signaling was examined by Western blotting, and STATTIC was used to inhibit STAT3 signaling.

Results

ARHGEF15 overexpression promoted the migration of HUVECs, and ARHGEF15 knockdown inhibited the migration of HUVECs. Neither the overexpression nor the knockdown of ARHGEF15 affected HUVEC proliferation.

Furthermore, ARHGEF15 increased STAT3 phosphorylation in HUVECs. STATTIC treatment prevents ARHGEF15 overexpression-induced STAT3 phosphorylation and HUVEC migration.

Conclusion

ARHGEF15 increases HUVEC migration by regulating STAT3 signaling.

Keywords

Rho guanine nucleotide exchange factor 15 (ARHGEF15) / Endothelial cell / Migration / STAT3 / Human umbilical vein endothelial cell (HUVEC)

References

[1] Sundararaman A, Mellor H. A functional antagonism between RhoJ and Cdc42 regulates fibronectin remodelling during angiogenesis. Small GTPases. 2021;12(4):241–245.

[2] Teleanu RI, Chircov C, Grumezescu AM, et al. Tumor angiogenesis and anti-angiogenic strategies for cancer treatment. J Clin Med. 2019;9(1):84.

[3] Liu ZL, Chen HH, Zheng LL, et al. Angiogenic signaling pathways and anti-angiogenic therapy for cancer. Signal Transduction Targeted Ther. 2023;8(1):198.

[4] Fukushima H, Yasumoto M, Ogasawara S, et al. ARHGEF15 overexpression worsens the prognosis in patients with pancreatic ductal adenocarcinoma through enhancing the motility and proliferative activity of the cancer cells. Mol Cancer. 2016;15(1):32.

[5] Lugano R, Ramachandran M, Dimberg A. Tumor angiogenesis: causes, consequences, challenges and opportunities. Cell Mol Life Sci: CMLS. 2020;77(9):1745–1770.

[6] Guo L, Dong F, Hou Y, et al. Dihydroartemisinin inhibits vascular endothelial growth factor-induced endothelial cell migration by a p38 mitogen-activated protein kinase-independent pathway. Exp Ther Med. 2014;8(6):1707–1712.

[7] Ogita H, Kunimoto S, Kamioka Y, et al. EphA4-mediated rho activation via vsm-RhoGEF expressed specifically in vascular smooth muscle cells. Circ Res. 2003;93(1):23–31.

[8] Takase H, Matsumoto K, Yamadera R, et al. Genome-wide identification of endothelial cell-enriched genes in the mouse embryo. Blood. 2012;120(4):914–923.

[9] Ding X, Chen Y, Guo C, et al. Mutations in ARHGEF15 cause autosomal dominant hereditary cerebral small vessel disease and osteoporotic fracture. Acta Neuropathol. 2023;145(5):681–705.

[10] Kusuhara S, Fukushima Y, Fukuhara S, et al. Arhgef15 promotes retinal angiogenesis by mediating VEGF-induced Cdc42 activation and potentiating RhoJ inactivation in endothelial cells. PLOS One. 2012;7(9):e45858.

[11] Sell GL, Schaffer TB, Margolis SS. Reducing expression of synapse-restricting protein Ephexin5 ameliorates alzheimer’s-like impairment in mice. J Clin Invest. 2017;127(5):1646–1650.

[12] Veeramah KR, Johnstone L, Karafet TM, et al. Exome sequencing reveals new causal mutations in children with epileptic encephalopathies. Epilepsia. 2013;54(7):1270–1281.

[13] Li G, Gao J, Ding P, et al. The role of endothelial cell-pericyte interactions in vascularization and diseases. J Adv Res. 2025;67:269–288.

[14] Arciniegas E, Carrillo LM, Rojas H, et al. Plump endothelial cells integrated into pre-existing venules contribute to the formation of “mother” and “daughter” vessels in pyogenic granuloma: Possible role of galectin-1, -3 and -8. Scars Burns Heal. 2021;7:2059513120986687.

[15] Wei T, Liu J. Anti-angiogenic properties of artemisinin derivatives (review). Int J Mol Med. 2017;40(4):972–978.

[16] Jia Y, Wang Q, Liang M, et al. KPNA2 promotes angiogenesis by regulating STAT3 phosphorylation. J Transl Med. 2022;20(1):627.

[17] She X, Xu J, Zhang H, et al. ETHE1 dampens colorectal cancer angiogenesis by promoting TC45 dephosphorylation of STAT3 to inhibit VEGF-a expression. Cell Death Dis. 2024;15(8):631.

[18] Gao P, Niu N, Wei T, et al. The roles of signal transducer and activator of transcription factor 3 in tumor angiogenesis. Oncotarget. 2017;8(40):69139–69161.

[19] Dutzmann J, Daniel JM, Bauersachs J, et al. Emerging translational approaches to target STAT3 signalling and its impact on vascular disease. Cardiovasc Res. 2015;106(3):365–374.

[20] Li J, Huang H, Xu S, et al. Complement factor H inhibits endothelial cell migration through suppression of STAT3 signaling. Exp Ther Med. 2023;26(2):408.

[21] Chen F, Wu Y, Ke L, et al. ARHGEF15 in sertoli cells contributes to germ cell development and testicular immune privilege. Biol Reprod. 2022;107(6):1565–1579.

[22] Vigil D, Cherfils J, Rossman KL, et al. Ras superfamily GEFs and GAPs: Validated and tractable targets for cancer therapy? Nat Rev Cancer. 2010;10(12):842–857.

[23] Sui YB, Wang Y, Liu L, et al. Astragaloside IV alleviates heart failure by promoting angiogenesis through the JAK-STAT3 pathway. Pharm Biol. 2019;57(1):48–54.

[24] Wang L, Astone M, Alam SK, et al. Suppressing STAT3 activity protects the endothelial barrier from VEGF-mediated vascular permeability. Dis Model Mech. 2021;14(11):dmm049029.

[25] Liu L, McBride KM, Reich NC. STAT3 nuclear import is independent of tyrosine phosphorylation and mediated by importin-alpha3. Proc Natl Acad Sci USA, 2005, 102(23): 8150-8155

[26] Chen SH, Murphy DA, Lassoued W, et al. Activated STAT3 is a mediator and biomarker of VEGF endothelial activation. Cancer Biol Ther. 2008;7(12):1994–2003.

[27] Yahata Y, Shirakata Y, Tokumaru S, et al. Nuclear translocation of phosphorylated STAT3 is essential for vascular endothelial growth factor-induced human dermal microvascular endothelial cell migration and tube formation. J Biol Chem. 2003;278(41):40026–40031.

Funding

the National Nature Science Foundation of China(82241030)

the State Program of Scientific Research “Natural resources and the Environment”(3.01)

Academic Promotion Program of Shandong First Medical University(2019QL014)

Fund for Laboratory of Translational Medicine in Microvascular Regulation of The First Affiliated Hospital of Shandong First Medical University.

RIGHTS & PERMISSIONS

The Author(s), under exclusive licence to the Huazhong University of Science and Technology